Bioptigen Offers Deep Imaging SDOCT For Pre-Clinical Applications
The medical imaging device company, Bioptigen Inc., has created the commercial market's deepest spectral domain optical coherence tomography (SDOCT) imaging system for pre-clinical applications. Called the Envisu R4300, it is the first Fourier-domain OCT system with extended depth-imaging capability in the 800-nanometers wavelength band...